173 related articles for article (PubMed ID: 2327778)
1. Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.
Hayashi S; Norbeck DW; Rosenbrook W; Fine RL; Matsukura M; Plattner JJ; Broder S; Mitsuya H
Antimicrob Agents Chemother; 1990 Feb; 34(2):287-94. PubMed ID: 2327778
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiviral activities of carbocyclic oxetanocin analogues.
Maruyama T; Sato Y; Horii T; Shiota H; Nitta K; Shirasaka T; Mitsuya H; Honjo M
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2719-25. PubMed ID: 1963811
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
[TBL] [Abstract][Full Text] [Related]
4. The polysulphated polyxylan Hoe/Bay-946 inhibits HIV replication on human monocytes/macrophages.
von Briesen H; Meichsner C; Andreesen R; Esser R; Schrinner E; Rübsamen-Waigmann H
Res Virol; 1990; 141(2):251-7. PubMed ID: 2345812
[TBL] [Abstract][Full Text] [Related]
5. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
6. MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.
Bridges CG; Taylor DL; Ahmed PS; Brennan TM; Hornsperger JM; Navé JF; Casara P; Tyms AS
Antimicrob Agents Chemother; 1996 May; 40(5):1072-7. PubMed ID: 8723443
[TBL] [Abstract][Full Text] [Related]
7. Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture.
Hung LF; Brumbaugh AE; Bhatia G; Marion PL; Hung PP; Norbeck DW; Plattner JJ; Robinson WS
J Med Virol; 1991 Nov; 35(3):180-6. PubMed ID: 1804929
[TBL] [Abstract][Full Text] [Related]
8. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
Hayashi S; Phadtare S; Zemlicka J; Matsukura M; Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6127-31. PubMed ID: 3261865
[TBL] [Abstract][Full Text] [Related]
9. Carbocyclic oxetanocins lacking the C-3' methylene.
Wu J; Schneller SW; Seley KL
J Med Chem; 1997 Apr; 40(9):1401-6. PubMed ID: 9135038
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
Kageyama S; Mimoto T; Murakawa Y; Nomizu M; Ford H; Shirasaka T; Gulnik S; Erickson J; Takada K; Hayashi H
Antimicrob Agents Chemother; 1993 Apr; 37(4):810-7. PubMed ID: 8494379
[TBL] [Abstract][Full Text] [Related]
11. Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes.
Balzarini J; Perno CF; Schols D; De Clercq E
Biochem Biophys Res Commun; 1991 Jul; 178(1):329-35. PubMed ID: 2069572
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of compounds for anti-HIV activity.
Patience C; Moore J; Boyd M
Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
[TBL] [Abstract][Full Text] [Related]
13. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
Montefiori DC; Zhou JY
Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity of 9-[c-4,t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl]-9H-adenine.
Katagiri N; Nomura M; Sato H; Kaneko C; Yusa K; Tsuruo T
J Med Chem; 1992 May; 35(10):1882-6. PubMed ID: 1588565
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage.
Saville MW; Taga K; Foli A; Broder S; Tosato G; Yarchoan R
Blood; 1994 Jun; 83(12):3591-9. PubMed ID: 7911340
[TBL] [Abstract][Full Text] [Related]
18. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
19. Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages.
Perno CF; Yarchoan R; Balzarini J; Bergamini A; Milanese G; Pauwels R; De Clercq E; Rocchi G; Calio R
Antiviral Res; 1992 Apr; 17(4):289-304. PubMed ID: 1322645
[TBL] [Abstract][Full Text] [Related]
20. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
